SCHEMBL29880880

SCHEMBL29880880

COc1cccc(S(=O)(=O)N2CCN(c3ccc4oc(C(=O)O)cc4c3Br)CC2)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 1/20 0.56
▸ LMNA P02545 4/20 0.53
▸ TSHR P16473 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ PKM P14618 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ IDO1 P14902 2/20 0.49
▸ PKLR P30613 1/20 0.47
▸ MAPT P10636 3/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ HPGD P15428 1/20 0.45
▸ PTPN11 Q06124 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ CHRM5 P08912 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1883290 1.00 NR1H4 (0.56) NR1H4LMNATSHRMAPK1PKM
SCHEMBL1885524 0.90 NR1H4 (0.60) NR1H4LMNATSHRMAPK1PKM
SCHEMBL29880561 0.90 NR1H4 (0.60) NR1H4LMNATSHRMAPK1PKM
SCHEMBL1891959 0.90 NR1H4 (0.54) NR1H4LMNATSHRPKMALDH1A1
SCHEMBL16354126 0.88 LMNA (0.52) NR1H4LMNATSHRMAPK1PKM
SCHEMBL29880959 0.87 NR1H4 (0.59) NR1H4LMNATSHRMAPK1PKM
SCHEMBL1885228 0.87 NR1H4 (0.59) NR1H4LMNATSHRMAPK1PKM
SCHEMBL1881182 0.86 NR1H4 (0.61) NR1H4LMNATSHRALDH1A1MAPT
SCHEMBL29880988 0.86 NR1H4 (0.61) NR1H4LMNATSHRALDH1A1MAPT
SCHEMBL1893687 0.86 NR1H4 (0.59) NR1H4LMNATSHRPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110404073-B Methods and pharmaceutical compositions for treating hepatitis B virus infection 国家医疗保健研究所 2022-08-16 — — CN disclosed
Send feedback